• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Info Edge (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
532777
INE663F01032
535.8780107
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NAUKRI
50.75
62326.19
EPS(TTM)
Face Value()
Div & Yield %
18.94
2
0.87
 

Ajanta Pharma's Paithan unit concludes USFDA inspection
Apr 22,2026
Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.